Dna X Inc (SONM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 12,240 | 15,835 | 14,393 | 21,058 | 12,706 |
| Cost of Goods | 9,777 | 12,106 | 9,994 | 16,140 | 10,541 |
| Gross Profit | 2,463 | 3,729 | 4,399 | 4,918 | 2,165 |
| Operating Expenses | 12,290 | 11,295 | 11,512 | 11,678 | 11,767 |
| Operating Income | -9,050 | -7,460 | -6,119 | -6,620 | -9,061 |
| Interest Expense | 0 | -44 | 182 | 302 | 319 |
| Other Income | -169 | -26 | -13 | 6 | -401 |
| Pre-tax Income | -9,219 | -7,442 | -6,314 | -6,916 | -9,781 |
| Income Tax | 61 | -1,034 | 150 | 180 | 183 |
| Net Income Continuous | -9,280 | -6,408 | -6,464 | -7,096 | -9,964 |
| Net Income | $-9,280 | $-6,408 | $-6,464 | $-7,096 | $-9,964 |
| EPS Basic Total Ops | -251.80 | 269.78 | -176.26 | -395.68 | -863.31 |
| EPS Basic Continuous Ops | -251.67 | 284.06 | -176.31 | -403.39 | -869.35 |
| EPS Diluted Total Ops | -251.80 | 269.78 | -176.26 | -395.68 | -863.31 |
| EPS Diluted Continuous Ops | -251.67 | 284.06 | -176.31 | -403.39 | -869.35 |
| EBITDA(a) | $-8,496 | $-7,053 | $-5,445 | $-5,860 | $-8,174 |